Shattuck Labs (STTK) Competitors $1.00 -0.06 (-5.24%) As of 02:19 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock STTK vs. OGI, NLTX, LRMR, INMB, VYGR, TLSA, VTYX, NVCT, IPHA, and PBYIShould you be buying Shattuck Labs stock or one of its competitors? The main competitors of Shattuck Labs include Organigram (OGI), Neoleukin Therapeutics (NLTX), Larimar Therapeutics (LRMR), INmune Bio (INMB), Voyager Therapeutics (VYGR), Tiziana Life Sciences (TLSA), Ventyx Biosciences (VTYX), Nuvectis Pharma (NVCT), Innate Pharma (IPHA), and Puma Biotechnology (PBYI). These companies are all part of the "pharmaceutical products" industry. Shattuck Labs vs. Its Competitors Organigram Neoleukin Therapeutics Larimar Therapeutics INmune Bio Voyager Therapeutics Tiziana Life Sciences Ventyx Biosciences Nuvectis Pharma Innate Pharma Puma Biotechnology Shattuck Labs (NASDAQ:STTK) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation, dividends and media sentiment. Do analysts recommend STTK or OGI? Shattuck Labs currently has a consensus price target of $7.50, indicating a potential upside of 662.20%. Given Shattuck Labs' higher probable upside, equities analysts plainly believe Shattuck Labs is more favorable than Organigram Global.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shattuck Labs 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 2.83Organigram Global 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders hold more shares of STTK or OGI? 58.7% of Shattuck Labs shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 12.0% of Shattuck Labs shares are held by insiders. Comparatively, 0.1% of Organigram Global shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more volatility & risk, STTK or OGI? Shattuck Labs has a beta of 1.72, suggesting that its share price is 72% more volatile than the S&P 500. Comparatively, Organigram Global has a beta of 1.37, suggesting that its share price is 37% more volatile than the S&P 500. Does the media prefer STTK or OGI? In the previous week, Shattuck Labs and Shattuck Labs both had 1 articles in the media. Shattuck Labs' average media sentiment score of 1.87 equaled Organigram Global'saverage media sentiment score. Company Overall Sentiment Shattuck Labs Very Positive Organigram Global Very Positive Which has better earnings & valuation, STTK or OGI? Organigram Global has higher revenue and earnings than Shattuck Labs. Shattuck Labs is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioShattuck Labs$5.72M8.24-$75.41M-$1.39-0.71Organigram Global$117.47M1.57-$33.39M$0.1013.75 Is STTK or OGI more profitable? Organigram Global has a net margin of 8.05% compared to Shattuck Labs' net margin of -1,156.46%. Organigram Global's return on equity of -5.93% beat Shattuck Labs' return on equity.Company Net Margins Return on Equity Return on Assets Shattuck Labs-1,156.46% -79.69% -69.13% Organigram Global 8.05%-5.93%-4.39% SummaryOrganigram Global beats Shattuck Labs on 8 of the 14 factors compared between the two stocks. Get Shattuck Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for STTK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding STTK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STTK vs. The Competition Export to ExcelMetricShattuck LabsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$47.13M$2.83B$5.42B$8.81BDividend YieldN/A2.69%5.37%4.21%P/E Ratio-0.7121.1425.5619.50Price / Sales8.24231.88374.5098.59Price / CashN/A43.0735.9456.46Price / Book0.597.227.855.49Net Income-$75.41M-$55.10M$3.15B$248.35M7 Day Performance0.99%0.99%1.01%2.01%1 Month Performance-8.89%7.93%5.24%5.73%1 Year Performance-74.04%0.26%38.87%18.07% Shattuck Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STTKShattuck Labs2.9303 of 5 stars$1.00-5.2%$7.50+653.8%-70.5%$47.66M$5.72M-0.72100OGIOrganigram1.3739 of 5 stars$1.43+2.1%N/A-11.4%$191.45M$194.09M-3.76860NLTXNeoleukin TherapeuticsN/A$19.76-3.1%N/A-44.7%$185.70MN/A-6.3590High Trading VolumeLRMRLarimar Therapeutics2.4456 of 5 stars$2.89+0.3%$19.67+580.5%-53.8%$185.04MN/A-2.5130Trending NewsAnalyst ForecastAnalyst RevisionINMBINmune Bio2.1776 of 5 stars$8.02+4.2%$22.80+184.3%+3.1%$184.33M$50K-3.6810High Trading VolumeVYGRVoyager Therapeutics3.9848 of 5 stars$3.31+0.3%$13.39+304.5%-62.4%$183.16M$66.96M4.66100TLSATiziana Life Sciences1.6147 of 5 stars$1.56+0.6%N/A+80.4%$182.28MN/A0.008VTYXVentyx Biosciences2.3536 of 5 stars$2.54-0.8%$10.00+293.7%+0.4%$180.75MN/A-1.0830NVCTNuvectis Pharma2.9491 of 5 stars$8.64+2.7%$17.00+96.8%+9.0%$180.52MN/A-7.458Positive NewsIPHAInnate Pharma3.2135 of 5 stars$1.86-1.8%$11.00+491.4%-8.8%$171.45M$12.62M0.00220Gap UpPBYIPuma Biotechnology4.1208 of 5 stars$3.45+3.0%$7.00+102.9%+11.8%$171.23M$232.71M7.19200 Related Companies and Tools Related Companies Organigram Competitors Neoleukin Therapeutics Competitors Larimar Therapeutics Competitors INmune Bio Competitors Voyager Therapeutics Competitors Tiziana Life Sciences Competitors Ventyx Biosciences Competitors Nuvectis Pharma Competitors Innate Pharma Competitors Puma Biotechnology Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:STTK) was last updated on 6/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump set to Boost Social Security Checks by 400%?If you're currently collecting—or planning to collect—Social Security benefits, there's an urgent development ...InvestorPlace | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shattuck Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shattuck Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy STTK Stock Free STTK Stock Alerts